NASDAQ · Analyst Forecast

Repligen Corporation (RGEN) Stock Forecast & Price Target

$162.18 NASDAQ: RGEN Market Cap $10.37B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Repligen Corporation (RGEN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Repligen Corporation, analysts forecast revenue rising from $733.09M in 2025 to $1.59B in 2030; the average estimate for 2030 earnings per share is $5.58; with published estimates ranging from $5.47 to $5.75; 16 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$162.18
Consensus targetThe average of the price targets analysts have published.$198.00
Median targetThe middle target, less affected by a single outlier.$200.00
Highest targetThe most optimistic published target.$225.00
Lowest targetThe most pessimistic published target.$160.00
Difference from priceHow far the consensus target sits from today’s price.+22.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$729.88M$733.09M$734.78M13
2026$828.43M$848.87M$858.00M15
2027$1.06B$1.07B$1.08B14
2028$1.20B$1.23B$1.31B16
2029$1.38B$1.40B$1.43B14
2030$1.57B$1.59B$1.63B14

Earnings per share forecast

YearLowAverageHighAnalysts
2025$1.64$1.66$1.6913
2026$2.05$2.07$2.0915
2027$2.48$2.66$2.7814
2028$0.55$3.42$4.2816
2029$4.35$4.44$4.5714
2030$5.47$5.58$5.7514

Repligen Corporation (RGEN) forecast — frequently asked questions

What is the analyst price target for Repligen Corporation?

Analysts covering Repligen Corporation (RGEN) have a consensus price target of $198.00, 22.1% above the current price of $162.18. Published targets range from $160.00 to $225.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Repligen Corporation's earnings?

The average analyst estimate for Repligen Corporation (RGEN) earnings per share in 2030 is 5.58, with individual estimates between 5.47 and 5.75.

How much revenue is Repligen Corporation expected to make?

Analysts forecast Repligen Corporation (RGEN) revenue of $1.59B in 2030, based on 14 published estimates.

How many analysts cover RGEN?

16 analysts contribute estimates for Repligen Corporation (RGEN). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Instruments & Supplies stocks

BDX forecastMDLN forecastWST forecastSOLV forecastBAX forecastCOO forecastAVTR forecastATR forecastBLCO forecastTFX forecastAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.